KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Total Liabilities: 2009-2025

Historic Total Liabilities for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Sep 2025 value amounting to $32.6 billion.

  • Teva Pharmaceutical Industries' Total Liabilities fell 7.84% to $32.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $32.6 billion, marking a year-over-year decrease of 7.84%. This contributed to the annual value of $33.6 billion for FY2024, which is 4.94% down from last year.
  • Per Teva Pharmaceutical Industries' latest filing, its Total Liabilities stood at $32.6 billion for Q3 2025, which was down 2.09% from $33.3 billion recorded in Q2 2025.
  • In the past 5 years, Teva Pharmaceutical Industries' Total Liabilities registered a high of $38.0 billion during Q1 2021, and its lowest value of $32.1 billion during Q1 2025.
  • Moreover, its 3-year median value for Total Liabilities was $34.8 billion (2024), whereas its average is $34.3 billion.
  • As far as peak fluctuations go, Teva Pharmaceutical Industries' Total Liabilities rose by 1.92% in 2024, and later dropped by 8.75% in 2025.
  • Quarterly analysis of 5 years shows Teva Pharmaceutical Industries' Total Liabilities stood at $36.4 billion in 2021, then fell by 2.77% to $35.4 billion in 2022, then dropped by 0.17% to $35.4 billion in 2023, then fell by 4.94% to $33.6 billion in 2024, then dropped by 7.84% to $32.6 billion in 2025.
  • Its Total Liabilities was $32.6 billion in Q3 2025, compared to $33.3 billion in Q2 2025 and $32.1 billion in Q1 2025.